Logos Global Management LP Rocket Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

$1.07 Billion
Q2 2024

A detailed history of Logos Global Management LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 350,000 shares of RCKT stock, worth $5.9 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

350,000

Previous 350,000 -0.0%

Holding current value

$5.9 Million

Previous $7.54 Million -0.0%

% of portfolio

0.71%

Previous 0.71%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$20.66 - $26.72 $19.6 Million - $25.4 Million	-950,000 Reduced 73.08%	350,000 $7.54 Million
Q1 2024 May 15, 2024	BUY	$26.16 - $30.74 $654,000 - $768,500	25,000 Added 1.96%	1,300,000 $35 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $11.7 Million - $22.4 Million	-700,000 Reduced 35.44%	1,275,000 $38.2 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $26 Million - $41.5 Million	1,725,000 Added 690.0%	1,975,000 $40.5 Million
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $10.8 Million - $15.3 Million	-650,000 Reduced 72.22%	250,000 $4.97 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $2.37 Million - $3.39 Million	150,000 Added 20.0%	900,000 $15.4 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $11.6 Million - $17.1 Million	750,000 New	750,000 $14.7 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $3.08 Million - $4.29 Million	-150,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $1.79 Million - $3.03 Million	134,191 Added 848.83%	150,000 $3.14 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $2.02 Million - $5.21 Million	-207,528 Reduced 92.92%	15,809 $221,000
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $2.47 Million - $5.41 Million	223,337 New	223,337 $5.08 Million

Others Institutions Holding RCKT

# of Institutions

197

Shares Held

92.7M

Call Options Held

222K

Put Options Held

111K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.28B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Account

Logos Global Management LP Rocket Pharmaceuticals, Inc. Transaction History